Aptamer Group plc provides aptamer selection and development services, focusing on the creation of aptamer-based reagents. The company operates through three divisions: custom services, diagnostics, and therapeutics. Its business model involves offering research and bioprocessing tools to various sectors within the life sciences, serving customers in therapeutic, diagnostic, and target-binding applications globally.